The landscape of American drug policy stands at a potential crossroads, where decades of federal classification systems may face significant revision. Recent discussions within political circles have focused attention on one of the most debated substances in American law enforcement and public health policy, suggesting that fundamental changes to federal drug scheduling could be on the horizon.
These conversations represent more than policy adjustments; they reflect evolving national attitudes toward substances that have been central to criminal justice debates for generations.
